'Workstreet fits at the intersection of two powerful trends: the expansion of cybersecurity spending, as well as the growing complexity of regulatory compliance,' Coalesce Capital founder Stephanie Geveda tells PE Hub.

BioMate partners with Vanta and Workstreet on SOC 2 & HIPAA compliance. BioMate is strengthening its security and compliance posture through partnerships with Vanta and Workstreet - building a continuous, automated program for SOC 2 and HIPAA that gives its biopharma and clinical partners the assurance they require before putting sensitive data and regulated workflows on any platform. Its Partners Two organizations, one compliance foundation. Vanta is the leading automated security and compliance platform. It continuously monitors a company's security posture, collects audit evidence in real time, and provides a clear, auditable path to SOC 2 and HIPAA certification. Rather than treating compliance as a one-time audit event, Vanta makes it an always-on, automated capability - reducing manual burden on engineering and operations teams while giving customers and partners continuous visibility into security controls. Workstreet Workstreet is Vanta's largest and most credentialed services partner, home to more Vanta-certified professionals than any other firm. Workstreet advises organizations from initial Vanta implementation through ongoing trust-program management, ensuring teams extract full value from the platform and sustain their SOC 2 and HIPAA posture as they scale. Why It Matters Compliance as a foundation, not an afterthought. BioMate is built for the most sensitive data in science: patient cohort records, proprietary compound libraries, preclinical study results, and unpublished target hypotheses. Its biopharma and clinical partners don't just want powerful AI - they need to know it is secure, auditable, and HIPAA-compliant before the first byte of their data enters the platform. The Vanta partnership delivers continuous, automated evidence collection across its infrastructure - every security control monitored in real time, every audit artefact collected automatically. Workstreet's expertise ensures that implementation is right-sized for where BioMate is today and structured to sustain certification as BioMate grow. What this means for BioMate users Every workflow you run on BioMate already returns cited, QC-audited results. Now the platform layer underneath carries the same standard of rigor: SOC 2 and HIPAA controls, continuously monitored, independently verified - so your compliance team has the documentation they need without asking your science team to stop and produce it. Closing the loop on responsible AI for drug discovery. BioMate's QC-gated workflows are designed from the ground up for audit readiness - every analytical step logged, every finding cited, every parameter traceable to its source. This compliance infrastructure closes the loop at the platform level, ensuring that the system running your research meets the same standards you apply to the research itself. BioMate is grateful to Vanta and Workstreet for the partnership, and BioMate look forward to sharing more milestones as BioMate progress toward certification.